TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,595 | -1.5% | 297 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,666 | -4.7% | 297 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,895 | +5.7% | 297 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,633 | -99.9% | 297 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,852,000 | -7.6% | 297 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,170,000 | -2.0% | 297 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,253,000 | -52.3% | 297 | -50.0% | 0.00% | -33.3% |
| Q4 2021 | $8,913,000 | +83.2% | 594 | +100.0% | 0.00% | +50.0% |
| Q3 2021 | $4,865,000 | -2.7% | 297 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,999,000 | -17.5% | 297 | -10.5% | 0.00% | 0.0% |
| Q1 2021 | $6,062,000 | +0.3% | 332 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $6,042,000 | +2.0% | 332 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,923,000 | -40.3% | 332 | -40.0% | 0.00% | -50.0% |
| Q2 2020 | $9,915,000 | +123837.5% | 553 | 0.0% | 0.01% | +20.0% |
| Q1 2020 | $8,000 | -27.3% | 553 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $11,000 | +10.0% | 553 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $10,000 | +100.0% | 553 | +116.0% | 0.01% | +100.0% |
| Q2 2019 | $5,000 | 0.0% | 256 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $5,000 | – | 256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |